Correlation Between Larimar Therapeutics and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Larimar Therapeutics and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and NLS Pharmaceutics.
Diversification Opportunities for Larimar Therapeutics and NLS Pharmaceutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Larimar and NLS is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and NLS Pharmaceutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the NLS Pharmaceutics. But the stock apears to be less risky and, when comparing its historical volatility, Larimar Therapeutics is 4.73 times less risky than NLS Pharmaceutics. The stock trades about -0.3 of its potential returns per unit of risk. The NLS Pharmaceutics AG is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1.40 in NLS Pharmaceutics AG on September 13, 2024 and sell it today you would lose (0.31) from holding NLS Pharmaceutics AG or give up 22.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Larimar Therapeutics |
| NLS Pharmaceutics |
Larimar Therapeutics and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and NLS Pharmaceutics
The main advantage of trading using opposite Larimar Therapeutics and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |